NCX1 activation inhibitor (Axxam)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNCX1 activation inhibitor (Axxam)
Drug Alias Namesodium calcium exchanger 1 inhibitor (Axxam)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/calcium exchanger 1 inhibitors
TargetsSodium/calcium exchanger 1
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxxam Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxxam Spa
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A